Aurobindo Pharma Ltd (stock symbol: AUROPHARMA.NS) is a publicly traded company listed on NSE, operating within the PHARMA sector. As of the latest trading session, Aurobindo Pharma Ltd is trading at ₹1,108.87 with a market capitalization of 660.00B. The stock has experienced a decline of 1.79% in today's trading, reflecting bearish sentiment among market participants.
The day's trading range has been between ₹1,093.68 (low) and ₹1,127.61 (high), with an opening price of ₹1,139.35 compared to the previous close of ₹1,129.08. Approximately 13.70M shares have changed hands, indicating strong liquidity and active investor interest in this stock.
Key Market Metrics for AUROPHARMA.NS:
Investors tracking AUROPHARMA.NS should note that the P/E ratio of 25.09 indicates moderate market expectations for future growth. Understanding these fundamental metrics alongside technical price action gives investors a comprehensive view of Aurobindo Pharma Ltd's market position and future prospects on NSE.
The PHARMA sector has been an area of consistent interest for market participants. Companies within this sector demonstrate varying performance based on macroeconomic factors, regulatory changes, and company-specific developments. Aurobindo Pharma Ltd continues to adapt to market dynamics while maintaining its competitive positioning.
For technical analysis, traders monitor several key levels for AUROPHARMA.NS: support at ₹1,093.68 and ₹1,129.08, and resistance at ₹1,127.61. The P/E ratio of 25.09 provides valuation context, helping investors determine if Aurobindo Pharma Ltd is trading at a premium or discount relative to its earnings potential. Regular monitoring of quarterly results, management commentary, and sector-wide trends will help investors stay informed about AUROPHARMA.NS's trajectory on NSE.
The current live price of Aurobindo Pharma Ltd (AUROPHARMA.NS) is ₹1,108.87 as of the most recent market data update on NSE. This price reflects the last traded value and changes in real-time during market hours. Today's trading session opened at ₹1,139.35, compared to the previous day's close of ₹1,129.08.
The intraday price action for AUROPHARMA.NS shows a high of ₹1,127.61 and a low of ₹1,093.68, giving the stock a daily trading range of approximately ₹33.93. The stock has experienced a decline of 1.79% in today's session. The total volume traded stands at approximately 13.70M shares.
Key Market Metrics for AUROPHARMA.NS:
Market participants tracking AUROPHARMA.NS should note that these prices are live and updated from market data providers. The market cap of 660.00B places Aurobindo Pharma Ltd among significant companies listed on NSE. Trading volume of 13.70M shares suggests strong liquidity and active investor interest in this stock.
Understanding the price history of Aurobindo Pharma Ltd (AUROPHARMA.NS) is essential for both technical and fundamental analysis. The stock's current price of ₹1,108.87 can be better understood in the context of its recent trading patterns and long-term trends on NSE.
Today's price action shows AUROPHARMA.NS opening at ₹1,139.35 compared to the previous close of ₹1,129.08. The intraday high of ₹1,127.61 and low of ₹1,093.68 represent the price boundaries for today's trading session. The negative movement of 1.79% provides insight into the day's market sentiment toward Aurobindo Pharma Ltd.
For technical analysis, traders monitor several key levels for AUROPHARMA.NS:
The P/E ratio of 25.09 provides a valuation benchmark comparing Aurobindo Pharma Ltd's stock price to its earnings per share. These fundamental metrics, combined with technical price action, give investors a comprehensive view of AUROPHARMA.NS's current market position and future prospects on NSE.
Investors are advised to use the interactive chart above to analyze AUROPHARMA.NS's price trends across different timeframes — from intraday 1D charts for short-term traders to 1Y charts for long-term investors. The combination of fundamental analysis and technical chart patterns helps in making well-informed decisions about Aurobindo Pharma Ltd stock in the PHARMA sector.
Indian investors looking to purchase Aurobindo Pharma Ltd (AUROPHARMA.NS) shares have several reliable options through registered stockbrokers and trading platforms. The process of buying AUROPHARMA.NS shares in India involves opening a demat and trading account with a SEBI-registered broker, completing the KYC (Know Your Customer) process, and funding the account to start trading. Below are the most popular platforms for investing in AUROPHARMA.NS and other stocks on NSE.
Zerodha is India's largest retail stockbroker by active clients and offers a seamless platform for buying AUROPHARMA.NS shares. With Zerodha's Kite platform, you can trade Aurobindo Pharma Ltd stocks on NSE and BSE with zero brokerage on equity delivery trades. The account opening process is fully digital and can be completed in minutes. Open a Zerodha account here to start investing in AUROPHARMA.NS with zero brokerage on delivery trades and flat €20 per trade on intraday and F&O.
Groww offers an intuitive mobile-first investment platform that is perfect for beginners looking to buy Aurobindo Pharma Ltd shares. With a simple interface and educational resources, Groww makes it easy to invest in AUROPHARMA.NS and thousands of other stocks and mutual funds. The platform offers zero account opening fees and zero brokerage on equity delivery. Sign up on Groww to begin your investment journey with Aurobindo Pharma Ltd shares.
Angel One is another excellent choice for trading AUROPHARMA.NS stocks, offering advanced charting tools, research reports, and expert recommendations. The platform provides free equity delivery trades and a powerful mobile trading app. Angel One's research team publishes regular analysis on Aurobindo Pharma Ltd and other PHARMA sector stocks to help you make informed decisions. Open an Angel One account and get access to expert stock recommendations and advanced trading tools.
Steps to Buy AUROPHARMA.NS Shares in India:
Disclaimer: Investments in the stock market are subject to market risks. Past performance does not guarantee future returns. Please consult a financial advisor before making investment decisions.
Here are other stocks in the PHARMA sector that investors tracking Aurobindo Pharma Ltd (AUROPHARMA.NS) may also be interested in. These companies operate in similar business areas and their performance can provide context for sector-wide trends on NSE.
The current live price of Aurobindo Pharma Ltd (AUROPHARMA.NS) is ₹ as traded on NSE. This price updates in real-time during market hours. Investors tracking AUROPHARMA.NS can use the interactive chart on this page to monitor price movements across different timeframes and make informed trading decisions.
Indian investors can buy AUROPHARMA.NS shares by opening a demat and trading account with any SEBI-registered stockbroker such as Zerodha, Groww, or Angel One. The process involves completing online KYC verification with your Aadhaar and PAN cards, funding your trading account, and placing a buy order for the desired quantity on the NSE exchange. We recommend comparing brokerage fees and platform features before choosing a broker.
Aurobindo Pharma Ltd operates in the PHARMA sector and is listed on NSE. The company's stock performance is influenced by sector-specific trends, economic conditions, regulatory developments, and company-specific factors within the PHARMA industry. Investors should monitor sector performance alongside individual stock metrics for a comprehensive view.
The current market capitalization of Aurobindo Pharma Ltd is approximately 660.00B, placing it in the mid-cap category on NSE. The P/E ratio stands at 25.09, which provides a valuation benchmark comparing the stock price to earnings per share. These metrics help investors assess whether AUROPHARMA.NS is fairly valued compared to peers in the PHARMA sector.
Whether AUROPHARMA.NS (Aurobindo Pharma Ltd) is a good investment depends on your individual financial goals, risk tolerance, and investment horizon. The stock currently trades at ₹1,108.87 with a negative change of 1.79% today. The P/E ratio of 25.09 suggests moderate valuation. We recommend consulting a SEBI-registered financial advisor and using our interactive chart tools to conduct your own research before making investment decisions.